跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 87 条关于
“REIMAGINE”
全部
87
临床试验
25
药物
4
机构
2
资讯
56
9个月前
Novo Nordisk's CagriSema Outperforms Ozempic in Diabetes Trial, Company Plans Pediatric Obesity Study
去年
Vafidemstat Phase IIa Results Published: Shows Promise in Treating Psychiatric Aggression
去年
Xaira Therapeutics Appoints Jeff Jonker as President and COO to Scale AI-Driven Drug Discovery Platform
去年
Oryzon Submits Phase III Protocol for Vafidemstat in Borderline Personality Disorder, Targeting First FDA-Approved Treatment
10个月前
Oryzon Genomics Appoints Regulatory Expert to Advance Vafidemstat Phase III Program in Borderline Personality Disorder
上个月
AI Is Already Transforming Oncology Drug Design and Clinical Trials, AstraZeneca's Reis-Filho Tells AACR
7个月前
Watchmaker Genomics Licenses CRISPR-Cas9 Technology from Caribou Biosciences for Novel NGS Library Normalization
11个月前
Cleveland Clinic Partners with Khosla Ventures to Accelerate Healthcare Innovation Through Strategic Collaboration
4年前
DeepMind Launches Isomorphic Labs to Transform Drug Discovery Through AI Innovation
10个月前
YorLabs Receives FDA 510(k) Clearance for Zero-CapEx Intracardiac Imaging System
第 1 页,共 6 页
上一页
下一页